The oral thin films market is experiencing significant growth due to several key factors. Firstly, the rising demand for convenient and patient-friendly drug delivery systems has driven the adoption of oral thin films. These films offer advantages such as ease of administration, rapid disintegration, and precise dosing. Secondly, the expanding geriatric population and the increasing prevalence of chronic diseases have fueled the demand for innovative pharmaceutical solutions. Additionally, advancements in technology and manufacturing processes have led to the development of improved oral thin film formulations, enhancing their efficacy and safety. Moreover, the growing focus on personalized medicine and the surge in research and development activities are driving market expansion. Overall, the oral thin films market is poised for continued growth due to its numerous advantages and increasing demand for innovative drug delivery systems.
The global Oral Thin Films Market was valued at US$ 2,450.6 Mn in 2021 and is forecast to reach a value of US$ 4,379.9 Mn by 2028 at a CAGR of 8.7% between 2022 and 2028.
Major Players in the Oral Thin Films Industry:
1. C L Pharm
C L Pharm is a pharmaceutical company that specializes in the development and manufacturing of oral thin films. The company was founded in 1996 and is headquartered in China. It operates in multiple countries worldwide, including the United States, Europe, and Asia. However, there is no specific recent development available for C L Pharm in the field of oral thin films.
2. Cure Pharmaceutical
Cure Pharmaceutical is a leading drug delivery and development company that focuses on the oral thin film technology platform. It was founded in 2011 and is based in Oxnard, California. Cure Pharmaceutical operates in several countries globally, including the United States, Canada, and Mexico. In October 2022, Cure Pharmaceutical announced a partnership with Canna World Market to develop and distribute hemp-infused oral thin films, expanding its product portfolio in the field.
3. Sunovion Pharmaceuticals Inc.
Sunovion Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes innovative therapies for people with serious medical conditions. Although Sunovion Pharmaceuticals Inc. has a diverse product portfolio, there is no specific recent development available regarding oral thin films. The company was founded in 1984 and is headquartered in Marlborough, Massachusetts. Sunovion Pharmaceuticals Inc. operates in multiple countries worldwide, including the United States, Japan, and several European countries.